Brief introduction of afudin

Afuddin, a new drug for AIDS treatment developed by Zhengzhou University in cooperation with Henan Analytical Testing Research Center, was successfully developed by Professor Chang Junbiao of Zhengzhou University. Afuddin is an HIV reverse transcriptase (RT) inhibitor, which belongs to a new generation of AIDS drugs which is advanced internationally and initiated by China.

Afuddin was supported by the national "863" project and the key scientific and technological projects in Henan Province. On April 30th, 20 13, it was approved by the US Food and Drug Administration to enter the clinical trial. As of May, 20 13, the drug has been authorized by China for invention patent, and an international application has been submitted through the Patent Cooperation Treaty (PCT).